However, in obesity and T2D, these regulatory hubs are disrupted, primarily due to chronic low-grade inflammation and IL-6–induced hepcidin upregulation, which promotes FPN degradation and the associated intracellular iron binding, as described above. This evidence concerns the gene HAMP and obesity disorder.